D.P. Bezerra et al. / Mutation Research 652 (2008) 164–174 173
[6] S. Ganguly, S. Mula, S. Chattopadhyay, M. Chatterjee, An ethanol extract
of Piper betle Linn. mediates its anti-inflammatory activity via down-
regulation of nitric oxide, J. Pharm. Pharmacol. 59 (2007) 711–718.
[7] C.D. Dodson, L.A. Dyer, J. Searcy, Z. Wrigh, D.K. Letourneau,
Cenocladamide, a dihydropyridone alkaloid from Piper cenocladum,Phy-
tochemistry 53 (2000) 51–54.
[8] F. Cicero Bezerra Felipe, J. Trajano Sousa Filho, L.E. de Oliveira Souza,
J. Alexandre Silveira, D. Esdras de Andrade Uchoa, E. Rocha Silveira,
O. Deusdenia Loiola Pessoa, G.S. de Barros Viana, Piplartine, an amide
alkaloid from Piper tuberculatum, presents anxiolytic and antidepressant
effects in mice, Phytomedicine (2007).
[9] I.L. Tsai, F.P. Lee, C.C. Wu, C.Y. Duh, T. Ishikawa, J.J. Chen, Y.C. Chen,
H. Seki, I.S. Chen, New cytotoxic cyclobutanoid amides, a new furanoid
lignan and anti-platelet aggregation constituents from Piper arborescens,
Planta Med. 71 (2005) 535–542.
[10] S. Panda, A. Kar, Piperine lowers the serum concentrations of thyroid hor-
mones, glucose and hepatic 5
D activity in adult male mice, Horm. Metab.
Res. 35 (2003) 523–526.
[11] C.R. Pradeep, G. Kuttan, Effect of piperine on the inhibition of lung metas-
tasis induced B16F-10 melanoma cells in mice, Clin. Exp. Metastasis 19
(2002) 703–708.
[12] K. Selvendiran, S.M. Banu, D. Sakthisekaran, Oral supplementation of
piperine leads to altered phase II enzymes and reduced DNA damage and
DNA-protein cross links in Benzo(a)pyrene induced experimental lung
carcinogenesis, Mol. Cell. Biochem. 268 (2005) 141–147.
[13] K. Selvendiran, R. Padmavathi, V. Magesh, D. Sakthisekaran, Preliminary
study on inhibition of genotoxicity by piperine in mice, Fitoterapia 76
(2005) 296–300.
[14] K. Selvendiran, J. Prince Vijeya Singh, D. Sakthisekaran, In vivo effect
of piperine on serum and tissue glycoprotein levels in benzo(a)pyrene
induced lung carcinogenesis in Swiss albino mice, Pulm. Pharmacol. Ther.
19 (2006) 107–111.
[15] K. Selvendiran, C. Thirunavukkarasu, J.P. Singh, R. Padmavathi, D. Sak-
thisekaran, Chemopreventive effect of piperine on mitochondrial TCA
cycle and phase-I and glutathione-metabolizing enzymes in benzo(a)pyrene
induced lung carcinogenesis in Swiss albino mice, Mol. Cell. Biochem. 271
(2005) 101–106.
[16] C. de Mattos Duarte, H. Verli, J.X. de Araujo-Junior, I.A. de Medeiros,
E.J. Barreiro, C.A. Fraga, New optimized piperamide analogues with
potent in vivo hypotensive properties, Eur. J. Pharm. Sci. 23 (2004) 363–
369.
[17] R.S. Vijayakumar, N. Nalini, Efficacy of piperine, an alkaloidal constituent
from Piper nigrum on erythrocyte antioxidant status in high fat diet and
antithyroid drug induced hyperlipidemic rats, Cell Biochem. Funct. 24
(2006) 491–498.
[18] R.S. Vijayakumar, N. Nalini, Piperine, an active principle from Piper
nigrum, modulates hormonal and apo lipoprotein profiles in hyperlipidemic
rats, J. Basic Clin. Physiol. Pharmacol. 17 (2006) 71–86.
[19] S.W. Lee, M.C. Rho, H.R. Park, J.H. Choi, J.Y. Kang, J.W. Lee, K. Kim,
H.S. Lee, Y.K. Kim, Inhibition of diacylglycerol acyltransferase by alka-
mides isolated from the fruits of Piper longum and Piper nigrum, J. Agric.
Food Chem. 54 (2006) 9759–9763.
[20] Y.N. Singh, N.N. Singh, Therapeutic potential of kava in the treatment of
anxiety disorders, CNS Drugs 16 (2002) 731–743.
[21] J.R. Stohr, P.G. Xiao, R. Bauer, Constituents of Chinese Piper species and
their inhibitory activity on prostaglandin and leukotriene biosynthesis in
vitro, J. Ethnopharmacol. 75 (2001) 133–139.
[22] C.Y. Chu, J.P. Chang, C.J. Wang, Modulatory effect of piperine on
benzo[a]pyrene cytotoxicity and DNA adduct formation in V-79 lung
fibroblast cells, Food Chem. Toxicol. 32 (1994) 373–377.
[23] S. Unchern, K. Nagata, H. Saito, J. Fukuda, Piperine, a pungent alkaloid,
is cytotoxic to cultured neurons from the embryonic rat brain, Biol. Pharm.
Bull. 17 (1994) 403–406.
[24] A. Khajuria, R.K. Johrn, U. Zutshi, Piperine mediated alterations in lipid
peroxidation and cellular thiol status of rat intestinal mucosa and epithelial
cells, Phytomedicine 6 (1999) 351–355.
[25] D.P. Bezerra, F.O. Castro, A.P. Alves, C. Pessoa, M.O. Moraes, E.R. Sil-
veira, M.A. Lima, F.J. Elmiro, L.V. Costa-Lotufo, In vivo growth-inhibition
of Sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper,
Braz. J. Med. Biol. Res. 39 (2006) 801–807.
[26] D.P. Bezerra, G.C. Militao, F.O. de Castro, C. Pessoa, M.O. de Moraes, E.R.
Silveira, M.A. Lima, F.J. Elmiro, L.V. Costa-Lotufo, Piplartine induces
inhibition of leukemia cell proliferation triggering both apoptosis and
necrosis pathways, Toxicol. In Vitro 21 (2007) 1–8.
[27] H.M. Navickiene, S. Bolzani Vda, M.J. Kato, A.M. Pereira, B.W. Bertoni,
S.C. Franca, M. Furlan, Quantitative determination of anti-fungal and insec-
ticide amides in adult plants, plantlets and callus from Piper tuberculatum
by reverse-phase high-performance liquid chromatography, Phytochem.
Anal. 14 (2003) 281–284.
[28] C.K. Atal, K.L. Dhar, J. Singh, The chemistry of Indian Piper species,
Lloydia 38 (1975) 256–264.
[29] D. Burke, D. Dawson, T. Stearns, Methods in Yeast Genetics, Cold Spring
Harbor Laboratory Press, 2000.
[30] S. Snow, Absence of suppressible alleles at the his 1 locus of yeast, Mol
Gen Genet 164 (1971) 341–342.
[31] D.C. Hawthorne, R.K. Mortimer, Suppressors in yeast, Genetics 48 (1963)
617–620.
[32] R.C. Von Borstel, K.T. Cain, C.M. Steinberg, Inheritance of spontaneous
mutability in yeast, Genetics 69 (1971) 17–27.
[33] D.C. Hawthorne, Identification of nonsense codons in yeast, J. Mol. Biol.
43 (1969) 71–75.
[34] R.C. Schuller, R.C. Von Borstel, Spontaneous mutability in yeast. I. Stabil-
ity of lysine reversion rates to variation of adenine concentration, Mutat.
Res. 24 (1974) 17–23.
[35] A. Hartmann, G. Speit, The contribution of cytotoxicity to DNA-effects in
the single cell gel test (comet assay), Toxicol. Lett. 90 (1997) 183–188.
[36] A. Hartmann, A. Elhajouji, E. Kiskinis, F. Poetter, H. Martus, A. Fjallman,
W. Frieauff, W. Suter, Use of the alkaline comet assay for industrial geno-
toxicity screening: comparative investigation with the micronucleus test,
Food Chem. Toxicol. 39 (2001) 843–858.
[37] M. Wojewodzka, I. Buraczewska, M. Kruszewski, A modified neutral
comet assay: elimination of lysis at high temperature and validation of
the assay with anti-single-stranded DNA antibody, Mutat. Res. 518 (2002)
9–20.
[38] S.B. Nadin, L.M. Vargas-Roig, D.R. Ciocca, A silver staining
method for single-cell gel assay, J. Histochem. Cytochem. 49 (2001)
1183–1186.
[39] R.R. Tice, E. Agurell, D. Anderson, B. Burlinson, A. Hartmann, H.
Kobayashi, Y. Miyamae, E. Rojas, J.C. Ryu, Y.F. Sasaki, Single cell
gel/comet assay: guidelines for in vitro and in vivo genetic toxicology
testing, Environ. Mol. Mutagen. 35 (2000) 206–221.
[40] B. Burlinson, R.R. Tice, G. Speit, E. Agurell, S.Y. Brendler-Schwaab, A.R.
Collins, P. Escobar, M. Honma, T.S. Kumaravel, M. Nakajima, Y.F. Sasaki,
V. Thybaud, Y. Uno, M. Vasquez, A. Hartmann, Fourth international work-
group on genotoxicity testing: results of the in vivo comet assay workgroup,
Mutat. Res. 627 (2007) 31–35.
[41] I. Nicoletti, G. Magliorati, M.C. Pagliacci, F. Grignani, C. Riccardi, A rapid
and simple method for measuring thymocyte apoptosis by propidium iodide
staining and flow cytometry, J Immunol Methods 139 (1991) 271–279.
[42] J.M. Boeira, J. da Silva, B. Erdtmann, J.A. Henriques, Genotoxic effects
of the alkaloids harman and harmine assessed by comet assay and chromo-
some aberration test in mammalian cells in vitro, Pharmacol. Toxicol. 89
(2001) 287–294.
[43] J.M. Boeira, A.F. Viana, J.N. Picada, J.A. Henriques, Genotoxic and recom-
binogenic activities of the two beta-carboline alkaloids harman and harmine
in Saccharomyces cerevisiae, Mutat. Res. 500 (2002) 39–48.
[44] M.M. Cohen, Y. Shiloh, Genetic toxicology of lysergic acid diethylamide
(LSD-25), Mutat. Res. 47 (1977) 183–209.
[45] S. Ohmori, Y. Morimoto, Dihydroetorphine: a potent analgesic: pharma-
cology, toxicology, pharmacokinetics, and clinical effects, CNS Drug Rev.
8 (2002) 391–404.
[46] Y. Pommier, Topoisomerase I inhibitors: camptothecins and beyond, Nat.
Rev. Cancer 6 (2006) 789–802.
[47] J.N. Picada, R. Roesler, J.A. Henriques, Genotoxic, neurotoxic and
neuroprotective activities of apomorphine and its oxidized derivative 8-
oxo-apomorphine, Braz. J. Med. Biol. Res. 38 (2005) 477–486.